This inventor holds 7 USPTO granted patents and 1 published patent application. Top assignees: Ajinomoto Co., Ltd., Morishita Pharmaceuticals Co. Ltd.. Active years: 1976-1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kamakura, JA (1976)
- Kamakura, JP (1979 - 1986)
Company Filing History:

Years Active: 1976-1986
Title: Yasumi Yugari: Innovator in Amino Acid Derivatives
Introduction
Yasumi Yugari is a notable inventor based in Kamakura, Japan. He has made significant contributions to the field of amino acid derivatives, holding a total of 7 patents. His work focuses on the preparation and application of these derivatives, particularly in the development of antihypertensive drugs.
Latest Patents
Yugari's latest patents include innovative methods for preparing amino acid derivatives. One of his key inventions relates to an amino acid derivative represented by a specific formula, where various groups can represent hydroxyl, alkyloxy, aryloxy, arylkyloxy, alkyl, aryl, or aralkyl. Additionally, he has disclosed N-terminal phosphorus dipeptides that exhibit antihypertensive properties, showcasing the potential of his inventions in medical applications.
Career Highlights
Throughout his career, Yasumi Yugari has worked with prominent companies such as Ajinomoto Co., Ltd. and Morishita Pharmaceuticals Co. Ltd. His experience in these organizations has allowed him to refine his expertise in the field of amino acid derivatives and their applications in pharmaceuticals.
Collaborations
Yugari has collaborated with notable individuals in his field, including Shigebumi Hashimoto and Shumpei Sakakibara. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Yasumi Yugari's innovative work in amino acid derivatives and antihypertensive drugs highlights his significant impact on the pharmaceutical industry. His contributions continue to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile